Astrazeneca Pharma India's Stock Shows Positive Trend, Outperforms Market in Short and Long Term

Astrazeneca Pharma India, a midcap pharmaceutical company, saw a positive trend in its stock performance on November 12, 2024. The stock gained 6.03%, outperforming the sector by 5.59%. This comes after three consecutive days of falling stock prices, indicating a potential trend reversal.

The stock also showed high volatility, with an intraday volatility of 5.6%. This was calculated from the weighted average price, indicating a significant fluctuation in the stock's value throughout the day. However, despite this volatility, Astrazeneca Pharma India's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.

On the same day, the stock touched an intraday high of Rs 7746.55, a 7.17% increase from its previous closing price. This positive performance has led MarketsMOJO to give a 'Hold' call for the stock.

In comparison to the overall market performance, Astrazeneca Pharma India has outperformed the Sensex by 5.69% in just one day. Over the past month, the stock has also performed better than the Sensex, with a -1.03% change compared to the Sensex's -2.16% change.

Overall, Astrazeneca Pharma India's stock has shown a positive trend and has outperformed the market in both short-term and long-term performance. Investors may want to keep an eye on this midcap pharmaceutical company for potential future growth.